Does increased price competition reduce entry of new pharmaceutical products?
2011 (English)In: Advances in Management and Applied Economics, ISSN 1792-7544, Vol. 1, no 1, 1-14 p.Article in journal (Refereed) Published
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects of increased price competition due to the reform on the entry of new pharmaceutical products were studied. The results show that the reform did affect the entry behavior of generic manufacturers as they became more prone to enter new package sizes into the market after the reform, but also that there is considerable heterogeneity in entry behavior between different ATC-code groups for both brand name and generic products.
Place, publisher, year, edition, pages
2011. Vol. 1, no 1, 1-14 p.
Pharmaceutical industry, generic competition, generic drugs, brand name drugs
Research subject Economics
IdentifiersURN: urn:nbn:se:umu:diva-37229OAI: oai:DiVA.org:umu-37229DiVA: diva2:358428
FunderSwedish Competition Authority